fbpx

Day

februar 3, 2020
CAMBRIDGE, Mass., Jan. 31, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that on January 31, 2020 the Compensation Committee of Spero’s Board of Directors granted non-qualified stock option awards...

Nyheder

Ny test kan afsløre farlige modermærker
14. februar 2020
Brainy Days – rejs med ind i hjernen
10. februar 2020
Astma programmeres tidligt i livet
7. februar 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge